Børø S, Thoresen S, Helland Å(2022) Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 - 2020 - A population-based registry study from Norway Front Oncol, 12, 1017902 DOI 10.3389/fonc.2022.1017902, PubMed 36523970
Maggadóttir SM, Kvalheim G, Wernhoff P, Sæbøe-Larssen S, Revheim ME, Josefsen D, Wälchli S, Helland Å, Inderberg EM(2022) A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT) Front Oncol, 12, 1031232 DOI 10.3389/fonc.2022.1031232, PubMed 36439452
Chen J, Song Y, Li Y, Wei Y, Shen S, Zhao Y, You D, Su L, Bjaanaes MM, Karlsson A, Planck M, Staaf J, Helland Å, Esteller M, Shen H, Christiani DC, Zhang R, Chen F(2022) A trans-omics assessment of gene-gene interaction in early-stage NSCLC Mol Oncol, 17(1), 173-187 DOI 10.1002/1878-0261.13345, PubMed 36408734